A review of the literature shows that many patients with multiple sclerosis (MS) have turned to the use of complementary and alternative medicines (CAM).1-3 As a neurologist who specializes in the treatment of patients with MS, I receive frequent questions about alternative therapies from many of the patients I treat. As healthcare providers, we have a responsibility to guide our patients; however, most of us know little or nothing about CAM therapies. This makes sense, since there are few randomized controlled trials (RCTs) of CAM therapies in MS.
Read MoreWe encourage you to submit your questions on multiple sclerosis treatment and care to our Steering Committee. We post selected questions and corresponding answers. Read more
The addition of daclizumab to interferon beta treatment reduces brain lesion formation in patients with relapsing multiple sclerosis, possibly by increasing the number of a subset of natural killer cells, according to a study published online Feb. 16 in The Lancet Neurology.
Read MoreStudy findings could have implications for autism, stroke and other conditions.
Read More